Lv01
0 积分 2025-02-03 加入
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study
1小时前
已完结
A change in bile flow: looking beyond transporter inhibition in the development of drug-induced cholestasis
1小时前
求助中
Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis
1小时前
已完结
Epitope spreading in immune-mediated diseases: implications for immunotherapy
1小时前
已完结
Phase 1/2 study of the safety and tolerability of nivolumab plus crizotinib for the first-line treatment of anaplastic lymphoma kinase translocation-positive advanced non-small cell lung cancer (CheckMate 370)
1小时前
已完结
Immunological off-target effects of imatinib
1小时前
已完结
Imatinib mesylate-induced acute hepatitis with autoimmune features
1小时前
求助中
Oxidative stress is involved in dasatinib-induced apoptosis in rat primary hepatocytes
1小时前
已完结
Regorafenib impairs mitochondrial functions, activates AMP-activated protein kinase, induces autophagy, and causes rat hepatocyte necrosis
2小时前
已完结
Polymorphisms of CYP2D6 gene and gefitinib-induced hepatotoxicity
2小时前
已完结
皖公网安备34019202002308
